BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 30617956)

  • 1. The impact of antihypertensive pharmacotherapy on interplay between protein-bound uremic toxin (indoxyl sulfate) and markers of inflammation in patients with chronic kidney disease.
    Kaminski TW; Pawlak K; Karbowska M; Znorko B; Mor AL; Mysliwiec M; Pawlak D
    Int Urol Nephrol; 2019 Mar; 51(3):491-502. PubMed ID: 30617956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
    Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
    BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation and oxidation: do they improve after kidney transplantation? Relationship with mortality after transplantation.
    Cañas L; Iglesias E; Pastor MC; Barallat J; Juega J; Bancu I; Lauzurica R
    Int Urol Nephrol; 2017 Mar; 49(3):533-540. PubMed ID: 28013471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease.
    Lee BT; Ahmed FA; Hamm LL; Teran FJ; Chen CS; Liu Y; Shah K; Rifai N; Batuman V; Simon EE; He J; Chen J
    BMC Nephrol; 2015 May; 16():77. PubMed ID: 26025192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.
    Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N
    Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The progress of inflammation and oxidative stress in patients with chronic kidney disease.
    Xu G; Luo K; Liu H; Huang T; Fang X; Tu W
    Ren Fail; 2015 Feb; 37(1):45-9. PubMed ID: 25375354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of serum lncRNA H19 expression with inflammatory and oxidative stress markers and routine biochemical parameters in chronic kidney disease.
    Okuyan HM; Dogan S; Terzi MY; Begen MA; Turgut FH
    Clin Exp Nephrol; 2021 May; 25(5):522-530. PubMed ID: 33548016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Not all inflammatory markers are linked to kidney function: results from a population-based study.
    Pruijm M; Ponte B; Vollenweider P; Mooser V; Paccaud F; Waeber G; Marques-Vidal P; Burnier M; Bochud M
    Am J Nephrol; 2012; 35(3):288-94. PubMed ID: 22398717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study.
    Karu N; McKercher C; Nichols DS; Davies N; Shellie RA; Hilder EF; Jose MD
    BMC Nephrol; 2016 Nov; 17(1):171. PubMed ID: 27832762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of diabetes and oxidative stress on plasma CCL23 levels in patients with severe chronic kidney disease.
    Pawlak K; Myśliwiec M; Pawlak D
    Pol Arch Med Wewn; 2014; 124(9):459-66. PubMed ID: 24995525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress and inflammatory markers in relation to circulating levels of adiponectin.
    Gustafsson S; Lind L; Söderberg S; Zilmer M; Hulthe J; Ingelsson E
    Obesity (Silver Spring); 2013 Jul; 21(7):1467-73. PubMed ID: 23585283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Klotho restrain RIG-1/NF-κB signaling activation and monocyte inflammatory factor release under uremic condition.
    He T; Xiong J; Huang Y; Zheng C; Liu Y; Bi X; Liu C; Han W; Yang K; Xiao T; Xu X; Yu Y; Huang Y; Zhang J; Zhang B; Zhao J
    Life Sci; 2019 Aug; 231():116570. PubMed ID: 31207307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease.
    Okyay GU; Inal S; Oneç K; Er RE; Paşaoğlu O; Paşaoğlu H; Derici U; Erten Y
    Ren Fail; 2013; 35(1):29-36. PubMed ID: 23113674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indoxyl sulfate and atherosclerotic risk factors in hemodialysis patients.
    Taki K; Tsuruta Y; Niwa T
    Am J Nephrol; 2007; 27(1):30-5. PubMed ID: 17215572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.
    Gupta J; Mitra N; Kanetsky PA; Devaney J; Wing MR; Reilly M; Shah VO; Balakrishnan VS; Guzman NJ; Girndt M; Periera BG; Feldman HI; Kusek JW; Joffe MM; Raj DS;
    Clin J Am Soc Nephrol; 2012 Dec; 7(12):1938-46. PubMed ID: 23024164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis.
    Filiopoulos V; Hadjiyannakos D; Takouli L; Metaxaki P; Sideris V; Vlassopoulos D
    Int J Artif Organs; 2009 Dec; 32(12):872-82. PubMed ID: 20037892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of oxidative stress and cellular inflammation in patients with diabetic nephropathy and non-diabetic nephropathy being administered hemodialysis treatment due to chronic renal failure.
    Avci E; Cakir E; Cevher SC; Yaman H; Agilli M; Bilgi C
    Ren Fail; 2014 Jun; 36(5):767-73. PubMed ID: 24579657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoxyl sulfate and p-cresyl sulfate in chronic kidney disease. Could these toxins modulate the antioxidant Nrf2-Keap1 pathway?
    Stockler-Pinto MB; Fouque D; Soulage CO; Croze M; Mafra D
    J Ren Nutr; 2014 Sep; 24(5):286-91. PubMed ID: 24480117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of neopterin, inflammatory markers and oxidative stress indicators in hyperemesis gravidarum.
    Tunc SY; Agacayak E; Budak S; Tunc N; Icen MS; Findik FM; Ekinci A; Gul T
    J Obstet Gynaecol Res; 2016 Jun; 42(6):618-24. PubMed ID: 26834047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease.
    Claro LM; Moreno-Amaral AN; Gadotti AC; Dolenga CJ; Nakao LS; Azevedo MLV; de Noronha L; Olandoski M; de Moraes TP; Stinghen AEM; Pécoits-Filho R
    Toxins (Basel); 2018 Sep; 10(10):. PubMed ID: 30249039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.